Take heed to this text

Microbot Medical’s LIBERTY system is a single-use endovascular robotic surgical system. | Supply: Microbot Medical

Microbot Medical Inc., the developer of the LIBERTY Endovascular Robotic Surgical System, is constructing on the momentum from the constructive outcomes of its good laboratory practices, or GLP, pre-clinical examine. The corporate is including a scientific analysis affiliate to assist its pending investigational system exemption, or IDE, submission to start its first-in-human scientific trial. 

The scientific analysis affiliate (CRA) will be a part of the Braintree Mass.-based firm‘s established scientific crew within the U.S. The crew is led by Dr. Juan Diaz-Cartelle, chief medical officer of Microbot Medical. 

“Following the profitable completion of our pivotal GLP pre-clinical trial, and as we’re within the closing stage of submitting our IDE, having an in-house CRA is a key piece for establishing the precise infrastructure for scientific trial execution” mentioned Diaz-Cartelle in a launch.

Be taught from Agility Robotics, Amazon, Disney, Teradyne and lots of extra.

Microbot Medical goals to enhance endovascular surgical procedures 

Microbot Medical’s LIBERTY system goals to enhance the usage of surgical robotics in endovascular procedures. The system eliminates the necessity for giant, cumbersome, and costly capital tools, based on the firm. It will probably additionally scale back radiation publicity and doctor pressure. 

In December 2023, Microbot Medical accomplished a pre-clinical examine of its LIBERTY system. The pre-clinical examine is a mandatory step towards Microbot Medical’s IDE submission to the U.S. Meals and Drug Administration (FDA). In the course of the examine, three interventional radiologists used LIBERTY to carry out a complete of 96 robotic navigations. 

The radiologists used LIBERTY to look at and consider goal vessels with surrounding tissue microscopically after subjecting them to procedures utilizing a variety of commercially obtainable intravascular catheterization units. All of those units have been managed and manipulated with Microbot Medical’s system. 

LIBERTY is a single-use endovascular system. No devoted infrastructure is required to make use of the system. This could decrease obstacles to acquiring and utilizing the system, making the know-how obtainable to extra healthcare suppliers, claimed Microbot Medical. 

Microbot groups up with Corewell Well being

Microbot Medical is collaborating with Corewell Well being for a multi-phase mission to allow telerobotics between distant facilities. The settlement additionally consists of the mutual analysis of the LIBERTY system for distant procedures. 

Corewell Well being is a not-for-profit well being system with greater than 60,000 workers, together with over 11,500 physicians and superior follow suppliers, and greater than 15,000 nurses. It mentioned it gives care and providers in 21 hospitals, over 300 outpatient places, and a number of other post-acute services.

Microbot Medical mentioned it presents micro-robotic applied sciences to enhance scientific outcomes for sufferers and improve accessibility by the pure and synthetic lumens, or tubular buildings, throughout the human physique.